Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma

被引:22
作者
Abargel, A
Avinoach, I
Kravtsov, V
Boaz, M
Glezerman, M
Menczer, J [1 ]
机构
[1] Edith Wolfson Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol Unit, Holon, Israel
[2] Edith Wolfson Med Ctr, Dept Pathol, Holon, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
endometrial carcinoma; endometrial carcinosarcoma; p27; expression; p53;
D O I
10.1111/j.1048-891x.2004.014221.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the study was to assess both p27 and p53 expression in the stromal and epithelial component of carcinosarcoma and to assess if their expression in the latter is different than in endometrial carcinoma. Immunohistochemical staining for p27 and p53 was performed on paraffin-embedded tissue blocks of 18 uterine specimens with carcinosarcoma and their expression assessed. Their expression in the epithelial element was also compared to that in 35 paraffin-embedded tissue blocks of endometrial endometrioid carcinoma. Reduced p27 expression was observed in a similarly high proportion of the stromal (77.8%) as well as of the epithelial component (66.7%) of carcinosarcoma. Although statistically not significant, the proportion of reduced p27 expression in endometrial carcinoma (85.7%) was higher than in the epithelial element of carcinosarcoma. The percentage of p53 overexpression in both elements of carcinosarcomas and in endometrial carcinomas was low and also similar (27.8 and 20.0%, respectively). Our results indicate that reduced p27 expression is common and p53 overexpression is infrequent in carcinosarcoma. Their similar rates of expression in the stromal and epithelial elements of the tumor support the contention of a monoclonal origin of carcinosarcoma. Unexpectedly, reduced p27 expression is more common in endometrial carcinoma than in the epithelial element of carcinosarcoma, in spite of the less favorable prognosticators and outcome in the latter. Further studies of p27 expression in carcinosarcoma are indicated to establish its clinical value in this aggressive malignancy.
引用
收藏
页码:354 / 359
页数:6
相关论文
共 50 条
  • [41] Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines
    Lee, DW
    Park, SW
    Park, SY
    Heo, DS
    Kim, KH
    Sung, MW
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (08): : 706 - 715
  • [42] p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
    Singh, Naveena
    Piskorz, Anna M.
    Bosse, Tjalling
    Jimenez-Linan, Mercedes
    Rous, Brian
    Brenton, James D.
    Gilks, C. Blake
    Kobel, Martin
    JOURNAL OF PATHOLOGY, 2020, 250 (03) : 336 - 345
  • [43] Bcl-2 and p53 expression in stage I endometrial carcinoma
    Giatromanolaki, A
    Sivridis, E
    Koukourakis, MI
    Harris, AL
    Gatter, KC
    ANTICANCER RESEARCH, 1998, 18 (5B) : 3689 - 3693
  • [44] To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma
    Yadav, Anuja
    Sistla, Anuradha
    Swain, Meenakshi
    Gowrishankar, Swarnalata
    de Padua, Michelle
    Modi, Tejal
    Himabindu, Rallabandi
    Agarwal, Neha
    Kulkarni, Aditya
    Bhandari, Trilok
    Vudayaraju, Hemanth
    Chinnababu
    Reddy, Vijay
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2024, 67 (01) : 62 - 67
  • [45] p53 staining as a prognostic indicator in endometrial carcinoma
    Özsaran, AA
    Türker, S
    Dikmen, Y
    Erhan, Y
    Itil, I
    Terek, C
    Özdemir, N
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1999, 20 (02) : 156 - 159
  • [46] Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma
    Kunc, Michal
    Gabrych, Anna
    Rekawiecki, Bartlomiej
    Gorczynski, Adam
    Haybaeck, Johannes
    Biernat, Wojciech
    Czapiewski, Piotr
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (01): : 1 - 4
  • [47] P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMICAL ANALYSIS
    AMBROS, RA
    ROSS, JS
    KALLAKURY, BVS
    MALFETANO, J
    KIM, YR
    HWANG, J
    BREESE, K
    FIGGE, J
    MODERN PATHOLOGY, 1995, 8 (04) : 441 - 445
  • [48] Endometrioid Endometrial Carcinoma With Spindle Cells-Aberrant p16 and p53 Expression
    Sonawane, Snehal
    Elfituri, Osama
    Zhang, Yanmin
    Yordan, Edgardo
    Ree, Nicholas
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (02) : 203 - 207
  • [49] Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype
    Huvila, Jutta
    Thompson, Emily F.
    Vanden Broek, Jamie
    Lum, Amy
    Senz, Janine
    Leung, Samuel
    Gilks, C. Blake
    Kobel, Martin
    McAlpine, Jessica N.
    Jamieson, Amy
    HISTOPATHOLOGY, 2023, 83 (06) : 880 - 890
  • [50] PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma
    Inaba, F
    Kawamata, H
    Teramoto, T
    Fukasawa, I
    Inaba, N
    Fujimori, T
    ONCOLOGY REPORTS, 2005, 13 (01) : 17 - 24